Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited has announced a new proposal to issue 500,000 options expiring on May 31, 2027, at an exercise price of $0.93 each, with a proposed issue date of June 27, 2024. This move, aimed at raising capital, is pending approval by the ASX and could potentially influence the company’s stock performance.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
